A Multicenter, Randomized, Double-blind, Placebo Controlled, Clinical Trial to Evaluate the Safety, Tolerability and Preliminary Effectiveness of 2 Doses of Intradiscal rhGDF-5 (Single Administration) for the Treatment of Early Stage Lumbar Disc Deg

Status:
Completed

Trial end date:
2014-09-01

Target enrollment:

Participant gender:

Study to show the safety and tolerability of Intradiscal rhGDF-5 in subjects with early lumbar disc degeneration